Volume 1.19 | Jul 31

Intestinal Cell News 1.19 July 31, 2015
Intestinal Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ICN on Twitter
 
TOP STORY
Intestinal Inhibition of Atg7 Prevents Tumor Initiation through a Microbiome-Influenced Immune Response and Suppresses Tumour Growth
Researchers showed that autophagy is activated in the intestinal epithelium in murine and human colorectal cancer and that the conditional inactivation of Atg7 in intestinal epithelial cells inhibits the formation of pre-cancerous lesions in Apc+/− mice by enhancing anti-tumor responses. [Nat Cell Biol] Abstract
Free wallchart: The Intestinal Crypt
 
PUBLICATIONS (Ranked by impact factor of the journal)
INTESTINAL CANCERS & DISEASES

Preventing E-Cadherin Aberrant N-Glycosylation at Asn-554 Improves Its Critical Function in Gastric Cancer
Using transgenic mice models and human clinical samples, researchers demonstrated that N-acetylglucosaminyltransferase V-mediated glycosylation caused an abnormal pattern of E-cadherin expression in the gastric mucosa. [Oncogene] Abstract

PAK5-Mediated E47 Phosphorylation Promotes Epithelial–Mesenchymal Transition and Metastasis of Colon Cancer
Scientists found that p21-activated kinase 5 (PAK5)-mediated E47 phosphorylation promoted epithelial–mesenchymal transition in advanced colon cancer. PAK5 interacted with E47 and phosphorylated E47 on Ser39 under hepatocyte growth factor stimulation, which decreased cell–cell cohesion, increased cell migration and invasion in vitro and promoted metastasis in a xenograft model. [Oncogene] Abstract

Tight Junction CLDN2 Gene Is a Direct Target of the Vitamin D Receptor
Using whole body VDR-/- mice, intestinal epithelial VDR conditional knockout (VDRΔIEC) mice, and cultured human intestinal epithelial cells, investigators demonstrated that the CLDN2 gene is a direct target of the transcription factor VDR. [Sci Rep] Full Article

IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1
Given the role of IL-18 in cell adhesion and in protecting against colon cancer, the authors evaluated its role in eosinophil-mediated cytotoxicity against Colo-205, a human colon carcinoma cell line. [J Immunol] Abstract

Prognostic Relevance of LGALS3BP in Human Colorectal Carcinoma
The role of LGALS3BP in colorectal cancer (CRC) prognosis was investigated. They provided evidence that low expression of LGALS3BP participates in malignant progression of CRC and implicated poor prognosis. [J Transl Med] Full Article

Retinoic Acid Morpholine Amide (RAMA) Inhibits Expression of Fas Ligand through EP1 Receptor in Colon Cancer Cells
Investigators demonstrated that RAMA significantly suppressed FasL expression in colon cancer cells in a dose- and time-dependent manner. [Tumour Biol] Abstract

Distribution of Intestinal Stem Cell Markers in Colorectal Precancerous Lesions
The authors investigated the expression and distribution of intestinal stem cell markers in serrated polyps and conventional adenomas. [Histopathology] Abstract

INTESTINAL STEM CELL & ORGANOID RESEARCH

Small Molecule and RNAi Induced Phenotype Transition of Expanded and Primary Colonic Epithelial Cells
Scientists report primary and prolonged culture of normal porcine epithelial cells from colon for cell line development. In addition, a novel primary three-dimensional intestinal culture system was presented, which generated organoids composed of a highly polarized epithelial layer lining a core of subepithelial tissue. [Sci Rep] Full Article

Development of Simplified and Defined Cell Culture for hPSCs - Watch Now!
 
REVIEWS
Epigenetic Regulation of the Intestinal Epithelium
The authors describe the role that epigenetics plays in intestinal homeostasis and disease, with an emphasis on results from mouse models. They highlight the importance of producing and analyzing next-generation sequencing data detailing the epigenome from intestinal stem cell to differentiated intestinal villus cell. [Cell Mol Life Sci] Abstract

Visit our reviews page to see a complete list of reviews in the intestinal cell research field.
 
INDUSTRY NEWS
Arena Pharmaceuticals Initiates a Phase II Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases
Arena Pharmaceuticals, Inc. announced the initiation of patient screening in a Phase II proof-of-concept clinical trial of APD334 in ulcerative colitis. Discovered by Arena, APD334 is an oral, investigational, Sphingosine 1-Phosphate Subtype 1 (S1P1) receptor modulator with therapeutic potential in ulcerative colitis as well as other autoimmune diseases. [Arena Pharmaceuticals, Inc.] Press Release

University of Toronto to Transform Regenerative Medicine Thanks to Historic $114 Million Federal Grant
The University of Toronto is set to cement its position as one of the world’s leading centers for the design and manufacture of cells, tissues and organs that can be used to treat degenerative disease, thanks to a $114-million grant from the federal government. [University of Toronto] Press Release

CDRD & OICR Team up to Advance Cutting-Edge New Cancer Treatments
Two of Canada’s leading drug research and commercialization centers have announced a call for proposals to help bring new cancer treatments to patients through collaborative technology-development projects from academic investigators across Canada. [Center for Drug Research and Development (CDRD)] Press Release

From our sponsor: Culturing hematopoietic stem and progenitor cells? Download the technical bulletin.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Unit for Multidisciplinary Research in Biomedicine (UMIB) Summit 2015®
September 24-25, 2015
Porto, Portugal

Visit our events page to see a complete list of events in the intestinal cell research community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Fellow – Biotechnology (Qu Biologics Inc.)

Research Associate – Intestinal Cell Biology (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Biology Endoderm Lineages (STEMCELL Technologies Inc.)

Harry Eagle Scholar Awards for Postdoctoral Candidates (Albert Einstein College of Medicine of Yeshiva University)

Postdoctoral Research Fellow – Ex Vivo Tumor Organoid Models (Fred Hutchinson Cancer Research Center)

Postdoctoral Positions – Cancer Research (Rutgers University)

Postdoctoral Researcher – Immunology and Microbiology (New York University School of Medicine)

Postdoctoral Position – Intestinal Immunology (Shanghai Institute of Immunology)

Postdoctoral Position – Mechanics and Genetics of Embryonic and Tumoral Development (Institut Curie UMR 168)

Bioinformatician – Inflammatory Bowel and Immunobiology Research (Cedars Sinai Medical Center)

Postdoctoral Researcher – Intestinal Diseases (Royal College of Surgeons in Ireland)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Intestinal Cell News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Intestinal Cell News: Archives | Events | Contact Us